Ephedrine Sulfate in 0.9% Sodium Chloride Injection 50 mg/10 mL
Unit of Sale NDC 14789-0250-10
*Vial closure is not made with natural rubber latex
Order directly through your wholesaler or from Customer Service at (888) 806-4606
Unit of sale NDC 14789-0250-10
Size: 10 mL vials
Unit of sale: 10 vials per carton
For questions, please contact customer service at 888‑806‑4606.
The Nexus Difference
Committed to Quality — From Molecules to Medicine
Starting with the source
- After years of research & development, EMERPHED® completed a rigorous FDA approval process
- Consumers and health professionals rely on the drug approval process for verification of safety, effectiveness, and quality1
Partnering with the right CMO*
- Based in North America and Europe—highly regulated markets with strong compliance histories
*Contract Manufacturing Organization
Applying extra quality assurance
- EMERPHED® is terminally sterilized which means the product is sterilized in its final container, ensuring a high level of sterility assurance, aligning with FDA guidelines and cGMP2
- Testing does not occur just once—every single batch goes through rigorous testing before making it to the pharmacy shelf
Delivering when others fall short
- No supply disruption vs. 203 generic injectable shortages with other suppliers3
What important safety infomation should I know?
WARNINGS AND PRECAUTIONS
EMERPHED® can cause pressor effects with concomitant use with oxytocic drugs. Can also cause tachyphylaxis with repeated administration of ephedrine.
Most common adverse reactions during treatment: nausea, vomiting, and tachycardia.
To report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Can include: interactions that augment pressor effect; interactions that antagonize the pressor effect; guanethidine; rocuronium; epidural anesthesia; theophylline; cardiac glycosides.
Overdose of EMERPHED® can cause a rapid rise in blood pressure. In the case of an overdose, careful monitoring of blood pressure is recommended. If blood pressure continues to rise to an unacceptable level, parenteral antihypertensive agents can be administered at the discretion of the clinician.
INDICATIONS AND USAGE
Ephedrine Sulfate injection is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
For more information, see full Prescribing Information.